"A massive bladder stone, weighing nearly 11 ounces and causing severe kidney damage, has been linked to chronic opioid use in a 35-year-old man, revealing a potentially overlooked urological complication of substance abuse."
This unprecedented case, detailed in the European Journal of Case Reports in Internal Medicine, underscores the complex and sometimes hidden health consequences of long-term opioid consumption. While the mechanisms by which opioids affect bladder function are known, this report is the first to document a direct causal link between chronic opioid-induced urinary retention and the formation of giant bladder stones. The findings challenge existing assumptions about the typical demographics and causes of such large calculi, urging healthcare professionals to broaden their diagnostic inquiries, particularly in younger patients presenting with unexplained urinary symptoms and kidney impairment.
A 35-year-old man presented to a hospital in Athens with a constellation of concerning symptoms: a persistent fever, a history of painful urination, and a disrupted urine stream characterized by hesitancy and intermittency. Medical examinations revealed significantly elevated levels of serum creatinine at 2 mg/dl and urea at 80 mg/dl, both indicators of compromised kidney function. Further investigation with an ultrasound confirmed the presence of bilateral hydronephrosis – a swelling of both kidneys due to the backup of urine, with both ureters appearing distended.
The underlying cause of this severe urinary obstruction was revealed by an X-ray: the man’s bladder contained two large stones. The more substantial of the two was an extraordinary specimen, measuring an astonishing 60 by 45 by 30 millimeters and weighing a staggering 310 grams, equivalent to approximately 11 ounces. This colossal stone was not merely present; it had completely occupied the bladder cavity, effectively damming urine flow and leading to the observed kidney damage.
The case, published on July 13, is remarkable not only for the sheer size of the bladder stone but also for the absence of the typical predisposing factors. Bladder stones, in general, represent a small fraction, approximately 5 percent, of all urinary tract stones. Giant bladder stones, defined as those exceeding 4 centimeters in diameter and weighing over 100 grams, are exceptionally rare occurrences worldwide. In developed nations, these large stones are almost exclusively found in older men. This demographic is susceptible due to common age-related anatomical changes such as benign prostatic hyperplasia (enlarged prostate) or urethral strictures, which impede complete bladder emptying. The residual urine then becomes a breeding ground for mineral precipitation, fostering stone formation over time. This particular patient, being in his mid-thirties, did not exhibit these common anatomical explanations for urinary retention. Furthermore, while multiple stones can occur in up to 30 percent of cases, this patient presented with a single, gargantuan obstruction.
The distinguishing factor in this case, and the detail that his medical team flagged as novel, is the identified reason for the stone’s formation: a history of intravenous opioid use. While giant bladder stones have been reported in the past, often in younger individuals, the underlying etiology has remained elusive. For instance, a 2014 report from Tabriz, Iran, described an 826-gram stone in another 35-year-old man, with the authors noting the perplexing absence of any identifiable obstruction or foreign body. Similarly, a 2025 report detailed a two-pound stone in a 32-year-old man, who also suffered from urinary retention and painful urination, yet the question of stone formation remained largely unanswered. This new case offers a compelling potential explanation for these previously enigmatic occurrences.
The mechanism by which opioids interfere with bladder function is multifaceted and well-documented, even if the ultimate consequence of giant stone formation has not been previously recognized. Opioids possess anticholinergic properties that disrupt the normal micturition reflex, the complex neural pathway that signals the bladder to empty. These properties can increase the tone in the bladder sphincter, the muscle that controls the release of urine, thereby preventing complete evacuation. Additionally, certain opioids, such as morphine, can act directly on spinal receptors, leading to a relaxation of the bladder muscle itself. Research, including animal studies cited in the report, suggests that mu and delta opioid receptors in the central nervous system play a crucial role in this centrally mediated suppression of bladder motility.
This opioid-induced urinary retention shares a common pathway with other medications known to affect bladder function, including certain antidepressants, anticholinergics, alpha agonists, and antipsychotics. However, the chronic and sustained nature of opioid use is what distinguishes this case. When urine is not fully expelled from the bladder day after day, year after year, the stagnant urine creates an environment conducive to the precipitation of minerals, forming the nucleus of a stone. This prolonged stasis is precisely the condition required for stones to grow. It is important to note that recreational drug use, in general, can lead to a wide spectrum of urological complications, with the specific effects varying depending on the substance used. The authors of the study explicitly stated that "Hidden predisposing factors such as chronic substance abuse may result in chronic urinary retention" and subsequent stone formation, adding that no prior published case report had identified chronic substance abuse as the underlying pathology for giant bladder calculi.
The silent growth of bladder stones often means that symptoms are chronic and vague, easily dismissed or endured for extended periods before a thorough medical investigation is initiated. By the time this patient sought medical attention, the chronic urine backflow had already caused significant damage. Bilateral hydronephrosis was evident, signifying substantial impairment of kidney function. His urine culture also revealed a significant infection with Providencia stuartii, a bacterium often associated with urinary tract infections, present at 100,000 colony-forming units per milliliter. Furthermore, he had developed an ulcer on his left elbow, an unusual finding that may be related to systemic effects or complications arising from his condition. The authors highlighted that severe kidney impairment directly caused by bladder stones is uncommon, primarily because stones typically do not grow large enough to obstruct both ureters simultaneously.
The patient’s treatment was staged. Initially, he received broad-spectrum antibiotics, piperacillin-tazobactam, guided by the sensitivities of the cultured bacteria, to combat the urinary tract infection. Subsequently, he underwent an open cystolithotomy, a surgical procedure involving an incision into the bladder, performed under general anesthesia. Both stones were successfully removed without any intraoperative complications. Following the surgery, his serum creatinine levels progressively normalized, and his urinary symptoms resolved.
This case offers a critical clinical lesson, particularly concerning the scope of questions healthcare providers should pose. In young men presenting with urinary tract infection symptoms and unexplained kidney impairment, a large bladder stone may not be the immediate diagnostic consideration. The authors advocate for a more comprehensive initial workup for young men experiencing urinary symptoms. This should include a plain X-ray and ultrasound, alongside standard urinalysis and blood tests for creatinine, calcium, uric acid, sodium, and potassium. Crucially, when no clear anatomical cause for the symptoms is identified, a detailed and thorough history of substance use should be considered an essential component of the diagnostic process, rather than an optional inquiry.
It is imperative to acknowledge the limitations of this evidence. This is a single patient report, and as such, it cannot definitively establish the frequency with which opioid use leads to bladder stones or quantify the precise risk for individuals. The direct causal link between opioid-related urinary retention and the formation of this specific stone remains the treating team’s interpretation, albeit a strongly supported one. Nevertheless, the implications are significant. Individuals experiencing urinary difficulties, such as an inability to empty the bladder completely, a weak or interrupted urine stream, or recurrent urinary infections, particularly those on prescribed opioid therapy, are advised to proactively discuss these symptoms with their clinician. Prompt medical evaluation, rather than waiting for symptoms to resolve spontaneously, could lead to earlier diagnosis and intervention, potentially preventing severe complications like irreversible kidney damage. This case highlights the need for increased awareness among both medical professionals and patients about the potential long-term urological consequences of chronic opioid use.
